Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2025	Dec. 31, 2024
Current Assets
Cash	$ 34,393,410	$ 35,004,924
Accounts receivable, net	10,192,774	8,217,813
Product deposit	191,840	40,763
Inventory, net	2,967,697	2,797,358
Other current assets	2,227,200	2,672,231
Total Current Assets	49,972,921	48,733,089
Non-current Assets
Equipment, net	1,438,829	1,479,184
Right of use assets	6,104,863	6,400,596
Capitalized software, net	14,311,592	13,816,501
Intangible assets, net	1,786,128	2,030,656
Total Non-current Assets	23,641,412	23,726,937
Total Assets	73,614,333	72,460,026
Current Liabilities
Accounts payable	15,679,028	16,009,484
Accrued expenses	18,503,380	20,811,763
Current operating lease liabilities	482,139	508,537
Current portion of long-term debt	11,611,111	8,444,444
Deferred revenue	14,625,902	14,480,917
Total Current Liabilities	60,901,560	60,255,145
Long-term Liabilities
Long-term debt, net	6,818,835	9,885,057
Noncurrent operating lease liabilities	6,186,692	6,265,192
Contingent consideration	100,000	100,000
Total Liabilities	74,007,087	76,505,394
Commitments and contingencies (Note 9)
Mezzanine Equity
Preferred Stock, $0.0001 par value; 5,000,000 shares authorized Series B Convertible Preferred Stock, $0.0001 par value; 5,000 shares authorized, zero shares issued and outstanding, liquidation value, $0 per share as of March 31, 2025 and December 31, 2024
Stockholders’ Deficit
Series A Preferred Stock, $0.0001 par value; 1,610,000 shares authorized, 1,400,000 shares issued and outstanding, liquidation value approximately, $25.55 per share as of March 31, 2025 and December 31, 2024	140	140
Common Stock, $0.01 par value; 100,000,000 shares authorized, 43,632,700 and 42,293,907 shares issued, 43,529,660 and 42,190,867 outstanding as of March 31, 2025 and December 31, 2024, respectively	436,327	422,939
Additional paid-in capital	233,043,479	230,508,339
Accumulated deficit	(235,644,977)	(236,253,218)
Treasury stock, 103,040, at cost, as of March 31, 2025 and December 31, 2024	(163,701)	(163,701)
Total LifeMD, Inc. Stockholders’ Deficit	(2,328,732)	(5,485,501)
Non-controlling interest	1,935,978	1,440,133
Total Stockholders’ Deficit	(392,754)	(4,045,368)
Total Liabilities, Mezzanine Equity and Stockholders’ Deficit	$ 73,614,333	$ 72,460,026